Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 4 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 7Gastrointestinal 4Thoracic 2Genitourinary 2Tumor-Agnostic 1Other hematologic neoplasm 1Other 1Lymphoid 1Head & Neck 1Gynecologic 1

Conditions

Head and Neck Neoplasms 1Agnosia 1

Interventions

Cisplatin 5lenvatinib 4Fentanyl 4Morphine 3Fluorouracil 3Docetaxel 3trametinib 2selpercatinib 2pralsetinib 2pembrolizumab 2nimotuzumab 2larotrectinib 2dabrafenib 2cabozantinib 2anlotinib 2Thyrotropin Alfa 2Saline Solution 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Norepinephrine 2Metformin 2Indocyanine Green 2Gabapentin 2Cinacalcet 2Cetuximab 2Carboplatin 2Benzydamine 2Acetaminophen 2xiaojin wan 1vandetanib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Bupivacaine × Head & Neck × Clear all
NCT04246697 2023-08-18

Multimodal Pain Study in Free Flap Patients

University of Kansas Medical Center

Phase 4 Completed
30 enrolled
Head & Neck

Agnosia, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡